Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage

Brain Research

Volumn 779, Issue 1-2, 1998, Pages 359-363

  Shimohama, S ^b   Greenwald, D L ^a   Shafron, D H ^a   Akaika, A ^b   Maeda, T ^b   Kaneko, S ^b   Kimura, J ^b   Simpkins, C E ^a   Day, A L ^a   Meyer, E M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

DMXB; Ischemia; Mecamylamine; Neuroprotection; Nicotinic; NMDA receptor

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; GLUTAMIC ACID; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEOCORTEX; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZYLIDENE COMPOUNDS; EXCITATORY AMINO ACID ANTAGONISTS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEURONS; NEUROPROTECTIVE AGENTS; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0031975130     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00194-7     Document Type: Article

References (13)

1. Akaike A., Tamura Y., Takeharu Y., Shimohama S., Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-asparate receptor-mediated glutamate cytotoxicity. Brain Res. 644:1994;181-186.
2. Alkondon M., Reinhardt S., Lobron C., Hermsen B., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons II. The rundown and inward rectifications of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization. J. Phamacol. Exp. Ther. 271:1994;494-499.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke. 17:1986;472-479.
4. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
5. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Miller N., Soledad V., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 5:1990;846-856.
6. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. USA. 86:1989;6421-6425.
7. Martin E.J., Panicker K.S., King M.A., Deyrup M., Hunter B.E., Meyer E.M. Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic cells. Drug Dev. Res. 31:1994;127-134.
8. Meyer E.M., De Fiebre C.M., Hunter B.E., Simpkins C.E., De Fiebre N.E. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31:1994;135-141.
9. Papke R.L., Bencherif M., Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype. Neurosci. Lett. 213:1996;201-204.
10. Pugh P.C., Berg D.K. Neuronal acetylcholine receptors that bind α-bungarotoxin mediate neurite retraction in calcuium-dependent manner. J. Neurosci. 14:1994;889-896.
11. Treinin M., Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron. 14:1995;871-877.
12. 2+. Neuron. 8:1992;353-362.
13. Wright S.C., Zhong J., Zheng H., Larrick J.W. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J. 7:1993;1045.